New Cancer Drug for Dogs Could Help People

OSU vet Cheryl London doses 3-year old Carter, a golden retriever diagnosed with lymphoma, with the new drug. Image courtesy of OSU.

Vets at Ohio State University are working with biotech firm Karyopharm to bring a new cancer therapy to market for dogs and people. They recently announced that the U.S. Food & Drug Administration had approved the drug for compassionate use in dogs with lymphoma–the first new option for dogs with the disease in more than two decades. Veterinarians will have limited access to the drug while the company works to complete the clinical trials necessary for a full approval.

OSU veterinarian Cheryl London led the trials of the drug, which works by preventing tumor-suppressing proteins from exiting the nucleus of cells–an action that normally allows cancer to grow out of control.

Read more here.


Introducing my new book Heal on the Vital Role of Dogs in Cancer Research

Arlene and MollyI am happy to announce that my second book is slated to be published in 2015 by ECW Press. It’s called Heal: The Vital Role of Dogs in the Search for Cancer Cures and it’s about the growing field of comparative oncology. This book offers an inside look at dogs in cancer research and the many innovative studies meant to help both dogs and people with the disease.

Did you know dogs and people get many of the same types of cancer, including lymphoma, melanoma, osteosarcoma, and breast cancer? Well, they do, and the veterinarians and oncologists in comparative oncology are doing important work that’s resulting in new treatments for both man and man’s best friend.

I also write about emerging research proving the remarkable ability of dogs to sniff cancer, and how everything scientists are learning about the dog’s nose may someday become the basis of new devices that can detect cancer early, when it may still be possible to cure it.

Watch here for updates on this exciting new book, and please sign up for my mailing list here.